The letter was described by people who had read ... It punctured the air of inevitability about the future of psychedelic medicine and led to a management shake-up and mass layoffs at Lykos ...

Polyrizon Ltd. has announced a non-binding Letter of Intent with a biotech company focused on psychedelic-derived therapeutics to develop a new intranasal formulation for treatment applications ...

“Our proprietary intranasal platform has the potential to enhance drug delivery bioavailability. We believe that intranasal delivery has the potential to improve patient outcomes by providing a ...